Germline met mutations in mice reveal mutation- and background-associated differences in tumor profiles.

by Carrie R Graveel, Jack D DeGroot, Robert E Sigler, George F Vande Woude
Published 2010-01-01

Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.

by Yu-Wen Zhang, Ben Staal, Karl J Dykema, Kyle A Furge, George F Vande Woude
Published 2012-01-01

HGF/SF Increases Tumor Blood Volume: A Novel Tool for the In Vivo Functional Molecular Imaging of Met

by Galia Tsarfaty, Gideon Y. Stein, Sharon Moshitch-Moshkovitz, Dafna W. Kaufman, Brain Cao, James H. Resau, George F. Vande Woude, Ilan Tsarfaty
Published 2006-05-01

Radioimmunoscintigraphy of Tumors Autocrine for Human Met and Hepatocyte Growth Factor/Scatter Factor

by Rick V. Hay, Brian Cao, R. Scot Skinner, Ling-Mei Wang, Yanli Su, James H. Resau, George F. Vande Woude, Milton D. Gross
Published 2002-01-01

In Vivo Direct Molecular Imaging of Early Tumorigenesis and Malignant Progression Induced by Transgenic Expression of GFP-Met

by Sharon Moshitch-Moshkovitz, Galia Tsarfaty, Dafna W. Kaufman, Gideon Y. Stein, Keren Shichrur, Eddy Solomon, Robert H. Sigler, James H. Resau, George F. Vande Woude, Ilan Tsarfaty
Published 2006-05-01

Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody

by Jianqun Kou, Phillip R. Musich, Ben Staal, Liang Kang, Yuan Qin, Zhi Q. Yao, Boheng Zhang, Weizhong Wu, Angela Tam, Alan Huang, Huai-Xiang Hao, George F. Vande Woude, Qian Xie
Published 2018-09-01